Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 1,489,000 | 2,133,414 | 2,123,524 | 1,943,240 | 1,911,900 |
| Cost of Goods | 536,340 | 485,010 | 501,710 | 465,090 | 426,790 |
| Gross Profit | 1,796,760 | 1,648,400 | 1,612,100 | 1,478,150 | 1,485,100 |
| Operating Expenses | 1,214,980 | 1,097,460 | 1,399,260 | 987,990 | 988,680 |
| Operating Income | -261,980 | 550,954 | 223,264 | 490,250 | 497,220 |
| Other Income | 944,690 | 25,506 | 53,906 | 38,110 | 298,090 |
| Pre-tax Income | 682,710 | 576,460 | 277,170 | 528,360 | 795,310 |
| Income Tax | 163,800 | 138,280 | 74,950 | 124,320 | 134,300 |
| Net Income Continuous | 332,000 | 438,180 | 189,538 | 404,040 | 661,010 |
| Net Income | $332,000 | $438,180 | $189,538 | $404,040 | $661,010 |
| EPS Basic Total Ops | 0.05 | 0.07 | 0.03 | 0.06 | N/A |
| EPS Basic Continuous Ops | 0.05 | 0.07 | 0.03 | 0.06 | N/A |
| EPS Diluted Total Ops | 0.05 | 0.07 | 0.03 | 0.06 | N/A |
| EPS Diluted Continuous Ops | 0.05 | 0.07 | 0.03 | 0.06 | N/A |
| EBITDA(a) | $-261,980 | $550,954 | $776,544 | $490,250 | $497,220 |